Primecap Management Co. CA reduced its holdings in shares of IMAX Corporation (NYSE:IMAX – Free Report) by 15.4% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 635,502 shares of the company’s stock after selling 116,100 shares during the quarter. Primecap Management Co. CA’s holdings in IMAX were worth $20,813,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also bought and sold shares of IMAX. Zhang Financial LLC purchased a new stake in shares of IMAX during the third quarter worth $903,000. Clearstead Advisors LLC purchased a new stake in IMAX during the 3rd quarter worth about $35,000. Aurora Investment Counsel lifted its holdings in IMAX by 0.4% during the 3rd quarter. Aurora Investment Counsel now owns 70,235 shares of the company’s stock worth $2,300,000 after purchasing an additional 308 shares in the last quarter. Citigroup Inc. boosted its stake in IMAX by 267.7% in the 3rd quarter. Citigroup Inc. now owns 66,769 shares of the company’s stock worth $2,187,000 after purchasing an additional 48,609 shares during the period. Finally, PNC Financial Services Group Inc. grew its holdings in IMAX by 5,223.6% during the 3rd quarter. PNC Financial Services Group Inc. now owns 9,689 shares of the company’s stock valued at $317,000 after buying an additional 9,507 shares in the last quarter. 93.51% of the stock is currently owned by hedge funds and other institutional investors.
IMAX Price Performance
Shares of IMAX stock opened at $42.86 on Friday. IMAX Corporation has a 1 year low of $20.48 and a 1 year high of $43.16. The firm has a market cap of $2.31 billion, a PE ratio of 69.13, a PEG ratio of 2.07 and a beta of 0.38. The company has a 50 day simple moving average of $36.44 and a two-hundred day simple moving average of $33.99.
Wall Street Analyst Weigh In
IMAX has been the topic of a number of recent analyst reports. Wedbush reissued an “outperform” rating and issued a $46.00 price target on shares of IMAX in a report on Monday, February 23rd. Roth Mkm reaffirmed a “buy” rating and set a $42.00 target price on shares of IMAX in a report on Monday, December 8th. The Goldman Sachs Group upgraded shares of IMAX from a “sell” rating to a “neutral” rating and increased their target price for the stock from $22.00 to $34.00 in a research note on Tuesday, November 25th. Weiss Ratings restated a “buy (b)” rating on shares of IMAX in a research report on Monday, December 29th. Finally, Macquarie Infrastructure upped their price target on shares of IMAX from $39.00 to $44.00 and gave the stock an “outperform” rating in a report on Thursday, January 15th. Ten investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, IMAX currently has a consensus rating of “Moderate Buy” and an average price target of $43.00.
View Our Latest Stock Analysis on IMAX
Trending Headlines about IMAX
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: Q4 earnings beat and strong growth — IMAX reported $0.58 EPS vs. $0.43 consensus and revenue of $125.2M (up ~35% y/y), driven by blockbuster titles and higher profitability. This is the primary catalyst for the stock move. Earnings Report
- Positive Sentiment: Analyst upgrades — JPMorgan raised its price target to $48 and kept an “overweight” rating, signaling meaningful upside; Benchmark also raised its target to $44 and reiterated a “buy”. Analyst bullishness supports further upside sentiment. Analyst Note Benchmark Note
- Positive Sentiment: Strong box-office backdrop and targets — Management outlined a $1.4B global box-office target for 2026 and is expanding premium content and network reach, suggesting recurring upside if tentpoles and slate perform. Box Office Target
- Positive Sentiment: Content wins and programming diversification — Dune 3 secured exclusive IMAX opening-weekend play in select markets (good for premium ticket sales), Studio Ghibli re-releases and live F1 broadcasts broaden non-traditional revenue streams. Dune 3 Article Ghibli Re-release F1 in IMAX
- Neutral Sentiment: Institutional support — Rosenblatt reiterated a buy and other boutiques remain constructive; this helps sentiment but is not new fundamental strength. Rosenblatt Note
- Neutral Sentiment: Investor materials available — The earnings call transcript and slide deck were published for deeper inspection; useful for gauging guidance and margin drivers but not an immediate price catalyst. Earnings Call Transcript
- Negative Sentiment: Opening-weekend windowing risk — Major title Avengers: Doomsday will not have an IMAX opening-weekend release in the U.S., which could blunt upside from that particular tentpole and offset some gains from other exclusives. Avengers Windowing
IMAX Profile
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Recommended Stories
- Five stocks we like better than IMAX
- Unlocked: Elon Musk’s Next Big IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- 1,500 Banks Just Handed the Fed Your Bank Account
- Read this or regret it forever
- Silver paying 20% dividend. Plus 68% share gains
Want to see what other hedge funds are holding IMAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IMAX Corporation (NYSE:IMAX – Free Report).
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
